This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dantz, D. Articles by Peters, A. Search for Related Content PubMed PubMed Citation Articles by Dantz, D. Articles by Peters, A.

Vascular Endothelial Growth Factor: A Novel Endocrine Defensive Response to Hypoglycemia

Departments of Internal Medicine I (D.D., J.B., B.F.-S., W.K., H.L.F, A.P.), Clinical Neuroendocrinology (J.B.), and Physiology (W.J.), University of Luebeck, Luebeck, Germany D-23538

Address all correspondence and requests for reprints to: Achim Peters, M.D., Medical University Luebeck, Department of Internal Medicine I, Ratzeburger Allee 160, D-23538 Luebeck, Germany.

Abstract

Glucose, the most important fuel for the brain, is supplied by the actions of counterregulatory hormones and the sympathetic nervous system. Yet to obtain access to the brain, glucose must pass the blood-brain barrier. Here we show that vascular endothelial growth factor (VEGF), a potent regulator of blood vessel function, is a candidate hormone for facilitating glucose passage across the blood-brain barrier under critical conditions. In 16 healthy men, VEGF serum concentrations increased under 6 h of insulin-induced hypoglycemic conditions from 86.1 ± 13.4 to 211.6 ± 40.8 pg/ml (P = 0.002), whereas in the hyperinsulinemic euglycemic control condition, no change was observed. During hypoglycemia serum VEGF, but no other counterregulatory hormone, was associated with preserved neurocognitive function, as measured with a memory test (r = 0.539; P = 0.031) and the Stroop interference task (r = 0.569; P = 0.021). Findings show that acute hypoglycemia is accompanied by a brisk increase in circulating VEGF concentration and that VEGF could mediate rapid adaptation of the brain to neuroglycopenia.

This article has been cited by other articles:

				U. Schweiger, W. Greggersen, S. Rudolf, M. Pusch, T. Menzel, S. Winn, J. Hassfurth, E. Fassbinder, K. G. Kahl, K. M. Oltmanns, et al. Disturbed Glucose Disposal in Patients With Major Depression; Application of the Glucose Clamp Technique Psychosom Med, February 1, 2008; 70(2): 170 - 176. [Abstract] [Full Text] [PDF]

				J. Luther, J. Milne, R. Aitken, M. Matsuzaki, L. Reynolds, D. Redmer, and J. Wallace Placental Growth, Angiogenic Gene Expression, and Vascular Development in Undernourished Adolescent Sheep Biol Reprod, August 1, 2007; 77(2): 351 - 357. [Abstract] [Full Text] [PDF]

				K. M. Oltmanns, H. Gehring, S. Rudolf, B. Schultes, C. Hackenberg, U. Schweiger, J. Born, H. L. Fehm, and A. Peters Acute hypoxia decreases plasma VEGF concentration in healthy humans Am J Physiol Endocrinol Metab, March 1, 2006; 290(3): E434 - E439. [Abstract] [Full Text] [PDF]

				F. A. Reed, J. M. Akey, and C. F. Aquadro Fitting background-selection predictions to levels of nucleotide variation and divergence along the human autosomes Genome Res., September 1, 2005; 15(9): 1211 - 1221. [Abstract] [Full Text] [PDF]

				J. W. Mastaitis, E. Wurmbach, H. Cheng, S. C. Sealfon, and C. V. Mobbs Acute Induction of Gene Expression in Brain and Liver by Insulin-Induced Hypoglycemia Diabetes, April 1, 2005; 54(4): 952 - 958. [Abstract] [Full Text] [PDF]

				R. M. Kraus, H. W. Stallings III, R. C. Yeager, and T. P. Gavin Circulating plasma VEGF response to exercise in sedentary and endurance-trained men J Appl Physiol, April 1, 2004; 96(4): 1445 - 1450. [Abstract] [Full Text] [PDF]